Atlas Trials

Can Beta-Hydroxy-beta-Methylbutyrate Supplementation Counteract Muscle Catabolism in Critically Ill Patients?

Clinical trial NCT03628365 · COMPLETED

Trial details

NCT number
NCT03628365
Sponsor
Mette M Berger
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Critical IllnessMuscle Weakness
Start date
2018-09-17
Primary completion
2020-01-06
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.